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The interaction of plasma proteins with metal oxide nanoparticles (NPs) is important due to the potential
biomedical application of these NPs. In this study, new approaches were applied to measure quantita-
tively the kinetics and afﬁnities of ﬁbrinogen and human serum albumin (HSA) for TiO2, CeO2, Al2O3 and
ZnO NPs immobilized on a sensor chip. Real-time surface plasmon resonance (SPR) measurements
showed that ﬁbrinogen interacted with TiO2 and CeO2 NPs with high afﬁnity (135 and 40 pM, respec-
tively) and to Al2O3 NPs with moderate afﬁnity (15 nM). The data ﬁtted well to the Langmuir model
describing a 1:1 interaction. In contrast, HSA interacted with TiO2, CeO2 and Al2O3 NPs with lower afﬁnity
(80 nM, 37 nM and 2 mM, respectively) with the data ﬁtting better to the conformational change model.
TiO2 and CeO2 NPs had fast association rate constants with ﬁbrinogen (1106 M1 s1) and Al2O3 NPs
had a slower association rate constant (1104 M1 s1). By contrast, HSA had markedly slower asso-
ciation rate constants (1103–1104 M1 s1). The binding of the proteins was reversible, thus al-
lowing the rapid capture of data for replicates. The occurrence of matrix effects was evaluated by using
surfaces with different chemistries to capture the NPs, namely alginate, NeutrAvidin and bare gold. The
afﬁnity values determined for the NP–protein interactions were largely independent of the underlying
surface used to capture the NPs.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The binding of proteins to different inorganic surfaces plays an
important role in natural processes such as the growth of bone
tissue (protein–mineral interactions), in biotechnological applica-
tions and in the medical implant sector (Lynch et al., 2007; Monti
et al., 2008). However, the mechanism for the interaction between
proteins and inorganic surfaces is complex and is still not fully
understood (Nakanishi et al., 2001).
Recently, the binding of proteins to metal oxide surfaces has
received increasing attention due to the important role that this
phenomenon plays in determining the biocompatibility of metal
oxide materials for use in medicine (Costa et al., 2013; Kang et al.,
2010) as well as in the preparation of new biosensors. For example,
the protein layer deposited on the surface of surgical metal im-
plants can induce early counterproductive immunologicalB.V. This is an open access article uresponses in patients (Monti et al., 2007; Vallee et al., 2010). The
physico-chemical properties of the NPs, such as composition, size,
charge and surface coating, can dramatically inﬂuence their in-
teraction with proteins (Mahmoudi et al., 2011) and thus their
possible future uses. To understand this binding fully it is neces-
sary to have knowledge not only of which proteins are attached to
the particles, but also their association and dissociation rates, af-
ﬁnity and the stoichiometry of the complexes (Aggarwal et al.,
2009). Several established techniques have been used to analyze
some of these parameters, including size-exclusion chromato-
graphy (SEC), isothermal titration calorimetry (ITC), quartz crystal
microbalance (QCM) and SPR (Cedervall et al., 2007; Klein, 2007).
SPR is a label-free technique that was introduced in the 1990s
to study interactions between biomolecules in real time and it was
mainly employed for antibody–antigen complexes (Liu et al.,
2006). In the last two decades, SPR has been extended to other
areas such as drug discovery and development, environmental
protection, food analysis, medical diagnostics, immunogenicity
and NP–protein interactions (Huber and Mueller, 2006; Karlsson,
2004; Xu et al., 2010). This technique provides the reactionnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the active concentration of bio-molecules in solution (Homola,
2008). SPR has been used to measure the interaction of ﬁbrinogen,
albumin and even whole plasma with two polymeric NPs. In that
work, the NPs were immobilized on the gold surface by chemical
modiﬁcation of the NPs with thiol groups (Cedervall et al., 2007).
However, chemical modiﬁcation could be a limiting factor in the
study of some NPs and the protein binding afﬁnity could be af-
fected by NP surface modiﬁcation. The direct capture of un-
modiﬁed NPs on the surface of the SPR chips will allow a more
realistic scenario for the analysis of the interaction between NPs
and proteins and this may help to predict the behavior of NPs in
body ﬂuids. To our knowledge, only Cohavi et al. (2011) have de-
scribed the direct immobilization onto an SPR chip surface and
they immobilized gold NPs onto a NeutrAvidin chip surface to
study the binding with peptides and proteins. In the work pre-
sented here we extended this study to a range of different, more
medically relevant, metal NPs.
In the present work, the binding of ﬁbrinogen and HSA to dif-
ferent metal oxide NPs, namely TiO2, CeO2, Al2O3 and ZnO, was
evaluated by SPR using the ProteOn™ XPR36 Protein Interaction
Array System (Bio-Rad). The kinetic binding constants and afﬁ-
nities of the interactions between NPs immobilized on the surface
of the chip and proteins passed over them as analytes were stu-
died with the aim of comparing the results for both proteins and
each type of metal oxide NP used. Three sensor chips with dif-
ferent chemical surfaces [compact alginate (GLC), NeutrAvidin
(NLC) and bare gold (BGD)] were used to capture the NPs in order
to examine whether the capture chemistry had an effect on the
interaction. For the interaction of HSA with Al2O3 NPs, the high
capacity alginate sensor chip (GLH) was also used to increase the
amount of NPs captured. For ZnO NPs, the interaction was studied
by immobilization of the NPs and injection of the proteins as
analytes and in reverse by immobilization of the proteins followed
by the injection of the ZnO NPs as analytes.2. Materials and methods
2.1. Reagents
GLC, GLH and NLC chips and SDS were purchased from Bio-Rad
(Bio-Rad Laboratories Inc.) and PBS buffer reagents (KCl, NaCl,
KH2PO4, Na2HPO4 and Tween-20) were purchased from Thermo
Fisher (Thermo Fisher Scientiﬁc Inc.).
2.2. Human serum proteins
Human serum albumin (HSA) (Z96%) and ﬁbrinogen were
both purchased from Sigma-Aldrich (LLC, St. Louis, MO). Fibrino-
gen had a purity of 50–70%, with approximately 15% of sodium
citrate and 25% of sodium chloride. The percentage of clottable
protein was Z80% from the total amount of ﬁbrinogen.
2.3. Nanoparticles
Four uncoated metal oxide nanoparticles were tested: TiO2 NPs
(3.5970.94 nm) and Al2O3 NPs (13.5678.37 nm), supplied by
PlasmaChem (Berlin, Germany), and CeO2 NPs (13.04712.13 nm)
and ZnO NPs (36.16718.27 nm), supplied by Evonik Industries AG
(Essen, Germany). NP size was determined by transmission elec-
tron microscopy (TEM) in the laboratory of Dr. Sergio Moya (CIC
Biomagune, San Sebastian, Spain). All NPs were suspended in
Milli-Q water (10 mg/ml) and sonicated in an ultrasound bath
(Selecta 300838, Ultrasons-H) at low frequency (40 kHz) for
20 min.The Dynamic Light Scattering (DLS) characterization of the NP
size and the Z-potential measurements were performed using a
Zetasizer Nano ZS from Malvern instruments at 25 °C. Suspensions
of NPs at 1 mg/ml in water were prepared for the Z-potential de-
termination. Each sample was measured 4 times, combining 200
runs per each one.
For NP size distribution analysis, NPs (25 mg/ml) were sus-
pended in water or PBS buffer and 3 measurements were aver-
aged, combining 13 runs per each one. The NP size distribution
was determined by intensity. The size and Z-potential character-
ization of the NPs are summarized in Table S6.
2.4. Immobilization of TiO2, CeO2, Al2O3 and ZnO NPs on different
commercial sensor chips
For further details, please see Supplementary information.
TiO2, CeO2, Al2O3 and ZnO NPs were directly immobilized by
physisorption (Elaissari, 2008) on different commercial SPR sensor
chips used in the ProteOnTM XPR36 instrument (Bio-Rad). TiO2,
CeO2 and Al2O3 NPs bind irreversibly with a high response (in
Response Units, RU) to alginate and NeutrAvidin surfaces. ZnO NPs
bind to the surfaces reversibly.
TiO2, CeO2, Al2O3 and ZnO NPs were applied at the concentra-
tions described (Supplementary information) to different ﬂow
cells in Milli-Q water at a ﬂow rate of 25 mL/min until an appro-
priate signal was reached. Another ﬂow cell was left blank to serve
as a reference channel (Fig. 2). Four different sensor chips were
used: GLC, GLH, NLC and BGD.
In the case of the BGD sensor chip, which has a low level of
charge and does not contain functional groups on the surface, the
NPs were directly immobilized, giving a high response. However,
after the protein injection, the signals presented drift and distor-
tion, and decreased in the consecutive sensorgrams, probably due
to a dissociation of the NPs from the surface. For that reason, the
direct immobilization of the TiO2 and CeO2 NPs on the chip pro-
duced an unstable surface so a different strategy was used for the
immobilization of these NPs. A stable surface of Al2O3 NPs (an
inert surface for ﬁbrinogen and HSA at the protein concentration
injected) was used as an intermediate surface, to which the NPs
could be easily immobilized (Fig. 1).
The Al2O3 NPs, at a concentration of 100 mg/mL in Milli-Q water,
were applied at a ﬂow rate of 25 mL/ min until a signal of about
3000 RU was reached in the three ﬂow cells. After injection, Milli-
Q water was passed through the system for 12 h until a stable
baseline was achieved. The TiO2 and CeO2 NPs, at the concentra-
tions described (Supplementary information) in Milli-Q water,
were then applied at the same ﬂow rate until an appropriate signal
was reached in two ﬂow cells. The Al2O3 ﬂow cell was used as a
reference to subtract possible interferences. The signals were ob-
tained by subtracting the signal observed on the Al2O3 NP channel
from those of the two ﬂow cells with the TiO2 or CeO2 NP chan-
nels. For the interaction with ﬁbrinogen, the Al2O3 NP reference
channel was 200 RU lower than that on the TiO2 NP channel, and
215 RU lower than the CeO2 NP channel. For the interaction with
HSA, the Al2O3 NP reference channel was 50 and 66 RU lower than
those of the TiO2 and CeO2 NP channels, respectively.
2.5. Protein injection and kinetic analysis
The interaction analyses with ﬁbrinogen and HSA were con-
ducted at 25 °C in PBST (10 mM Na2HPO4, 2 mM KH2PO4, 137 mM
NaCl, 2.7 mM KCl, 0.005% Tween 20, pH 7.4) unless stated
otherwise.
After the immobilization of the NPs, the buffer was changed to
PBST. The chip was then rotated by 90° and buffer injections were
performed until a stable signal was achieved (for at least 30 min).
Fig. 1. Immobilization and stabilization of the TiO2 or CeO2 NPs on an immobilized Al2O3 NP surface on a BGD sensor chip. (1) Al2O3 NPs were immobilized in vertical
channels one to three; (2) TiO2 or CeO2 NPs were immobilized in channels one and two, respectively. The third channel, with the immobilized Al2O3 NPs, was used as
reference channel.
Fig. 2. Workﬂow for the kinetic analysis of ﬁbrinogen and HSA interactions with immobilized NPs on a sensor chip: (1) the different NPs were immobilized by physisorption
in 4 vertical channels, leaving the ﬁfth as a reference channel; (2) different protein concentrations (ﬁbrinogen or HSA) and buffers were injected into the six horizontal or
analyte channels, and kinetic data were collected; (3) the proteins were stripped from the NPs, using SDS as a regeneration agent, to allow the repeat injection of the protein
samples.
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100 mL/min for 240 s in the association phase, which was followed
by a 600 s dissociation phase unless stated otherwise. In this
conﬁguration, up to ﬁve protein concentrations can be tested si-
multaneously for each NP sample immobilized on the sensor chip,
and running buffer was injected in the sixth channel to correct for
any drift (Fig. 2). The binding (association followed by dissociation
in buffer) was recorded in real time. The 66 architecture of the
chip allowed multiple measurements to be carried out in parallel
on a single chip (Bravman et al., 2006; Cohavi et al., 2009). Unless
stated otherwise, the NP surface was regenerated by injection of
0.5% sodium dodecylsulfate (SDS) at 100 mL/min for 120 s, which
allows the cycle to be repeated to obtain the results in triplicate
(Fig. 2).
The ﬁnal method was the result of extensive regeneration
scouting; NaOH, NaCl, HCl and MgCl2 were tested as regenerants
but they were found to be less effective at regenerating the NP
surface than an injection of 0.5% SDS.
2.5.1. Kinetic analysis of ﬁbrinogen with TiO2, CeO2, and Al2O3 NPs
The study was performed on a GLC surface. Kinetic binding
data were collected by injecting ﬁbrinogen (340 kDa) at ﬁve dif-
ferent concentrations (2352, 1176, 588, 294 and 147 pM for the
TiO2 NPs, 1176, 588, 294, 147 and 73.5 pM for the CeO2 NPs, and
147, 73.5, 36.8, 18.4 and 9.2 nM for the Al2O3 NPs) in channels 1–5,respectively. Running buffer was injected simultaneously in the
sixth channel to correct for drift. The data were ﬁtted to a 1:1
kinetic model using the grouped data analysis option.
The study was also performed on NLC and BGD surfaces. The
ﬁbrinogen was injected at concentrations (1176, 588, 294, 147 and
73.5 pM) for TiO2 and CeO2 NPs. In the case of CeO2 NPs, the
analysis was performed in duplicate on the three surfaces and
additional experiments were carried out in duplicate on the GLC
and NLC chips, and in a single experiment on the BGD surface, at
concentrations (2352, 1176, 588, 294 and 147 pM) on the GLC chip
(Fig. S1) and two times lower on the NLC and BGD surfaces (1176,
588, 294, 147 and 73.5 pM) (Figs. S2 and S3). For the Al2O3 NPs the
ﬁbrinogen was injected at concentrations (147, 73.5, 36.8, 18.4 and
9.2 nM).
2.5.2. Kinetic analysis of HSA on TiO2, CeO2, and Al2O3 NPs
The study was performed on a GLC surface. HSA (66 kDa) was
injected into three ﬂow cells (TiO2, CeO2 and reference surfaces) at
ﬁve different concentrations (755, 377.5, 188.8, 94.4 and 47.2 nM).
On the Al2O3 NP channel, the protein was injected at concentra-
tions 10 times higher than on the TiO2 and CeO2 NP channels (7.55,
3.77, 1.89, 0.94 and 0.47 mM). The data were ﬁtted to a conforma-
tional change model using the grouped data analysis option.
The results for the GLC surface were compared at the same
concentrations as for the TiO2 and CeO2 NPs on NLC and BGD
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(GLH) was used to enhance the immobilization levels. Two dif-
ferent experiments were performed (denoted GLH1 and GLH2).
The levels of immobilization achieved on the GLC, GLH1 and GLH2
surfaces were about 3000 RU, 9000 RU and 6500 RU, respectively.
The protein concentrations used were the same as on the GLC
surface in the GLH1 chip and 2 times higher (15.10, 7.55, 3.77, 1.89
and 0.94 mM) on the GLH2 chip.
2.6. Data processing and analysis
All binding sensograms were collected, processed and analyzed
using the integrated ProteOn ManagerTM Software version 3.1.
Binding curves for the ﬁbrinogen–NP interactions were ﬁtted
using the Langmuir model describing a 1:1 binding stoichiometry
(AþB2AB). Each of the NPs interacting with the ﬁve concentra-
tions of protein was ﬁtted using a grouped ka, kd, and Rmax. ka is the
association rate constant for the NP–ﬁbrinogen binding, kd is the
dissociation rate constant for the complex, Rmax describes the
signal (in RU) when all of the ligand binding sites are saturated by
the analyte, and Chi2 is the sum of different squares between the
data and the ﬁtted curves, divided by the number of the data
points and subtracted from the number of parameters. Afﬁnities
were calculated from the relation KD¼kd/ka, where KD is the
equilibrium dissociation constant. Binding curves for the HSA–NP
interactions were ﬁtted using the two states conformational
change model (AþB2AB2(AB)*), where AB is the ﬁrst con-Fig. 3. Binding curves for ﬁbrinogen with TiO2, CeO2 and Al2O3 NPs. (a) Sensorgrams
concentrations of ﬁbrinogen injected were 2352, 1176, 588, 294 and 147 pM. On the BG
73.5 pM. (b) Sensorgrams for the interaction of ﬁbrinogenwith CeO2 NPs. The concentrati
the interaction of ﬁbrinogen with Al2O3 NPs. The concentrations of ﬁbrinogen injectedformation of the bound complex and (AB)* is the second con-
formation of the bound complex. Each of the NPs interacting with
the ﬁve concentrations of protein was ﬁtted using a grouped ka1,
kd1, ka2, kd2, and Rmax. ka1 and kd1 are the association and dis-
sociation rate constants of the NP–HSA binding process and ka2
and kd2 are the rate constants of the conformational change. Af-
ﬁnities were calculated from the relation KD¼(kd1/ka1) (kd2/ka2),
where KD is the overall equilibrium dissociation constant. The
sensorgrams were plotted using Origin 8.0.3. Results
3.1. Kinetic analysis of ﬁbrinogen on TiO2, CeO2, Al2O3 and ZnO NPs
For the interaction of ﬁbrinogen with TiO2 NPs on the alginate
GLC surface, the afﬁnity was 206 pM with ka of 3.71106 M1 s1
and kd of 7.63104 s1 (Fig. 3a and Table 1). On using the NLC
and BGD surfaces, the afﬁnity values were slightly higher at 121
and 74 pM, respectively. This difference is due to the faster asso-
ciation constants on these surfaces (5.37106 M1 s1 and
6.26106 M1 s1, respectively). The results show that the afﬁ-
nities were similar on the GLC and NLC surfaces and slightly higher
on the BGD surface, but on the whole, the constants are compar-
able and it can be considered that the values reported are the
result of the ﬁbrinogen–TiO2 NP interaction and not due to a
matrix effect.for the interaction of ﬁbrinogen with TiO2 NPs. On the GLC and NLC surfaces the
D surfaces the concentrations of ﬁbrinogen injected were 1176, 588, 294, 147 and
ons of ﬁbrinogen injected were 1176, 588, 294, 147 and 73.5 pM. (c) Sensorgrams for
were 147, 73.5, 36.8, 18.4 and 9.2 nM.
Table 1
Binding constants for the interactions between ﬁbrinogen and TiO2, CeO2, and Al2O3 NPs.
NPs Chip ka (M1 s1) kd (s1) KD (M) Rmax (RU) Chi2 (RU)
TiO2 GLC 3.7170.02106 7.6370.04104 2.061010 81.54 8.04
TiO2 NLC 5.3770.02106 6.4870.03104 1.211010 80.54 8.44
TiO2 BGD 6.2670.03106 4.6470.04104 7.421011 93.29 9.99
CeO2 GLC 5.1370.02106 2.1770.04104 4.241011 61.60 4.01
CeO2 NLC 6.6570.03106 2.4570.04104 3.681011 84.03 9.19
CeO2 BGD 6.4170.02106 2.6070.03104 4.061011 108.98 6.39
Al2O3 GLC 4.2870.02104 7.1670.04104 1.67108 82.04 8.05
Al2O3 NLC 6.3070.03104 6.8870.04104 1.09108 58.73 6.07
Al2O3 BGD 5.9770.03104 8.0870.05104 1.35108 53.04 7.15
Three different chip surfaces were used: alginate (GLC), NeutrAvidin (NLC) and bare gold (BGD). The standard deviations quoted for the rate constants are the standard error
of the ﬁt from the global ﬁtting of 5 concentrations, each concentration performed in triplicate, except for the interactions of ﬁbrinogen with the CeO2 NPs, which was
performed in duplicate. The standard deviations for Rmax are in the range 0.31–0.13.
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seen in Fig. 3a. The Chi2 values, which are used to deﬁne how well
the generated kinetic parameters ﬁt to the chosen model – in this
case the 1:1 Langmuir model, were less than 10 for the ﬁbrinogen
TiO2 NP interaction (Table 1). This ﬁnding typically indicates that
the kinetic parameters obtained ﬁt well to the model. However, it
is also important to consider Chi2 in terms of its relationship to
Rmax, where Chi2 values that are less than 10% of the ﬁtted Rmax
indicate that the data ﬁt well to the Langmuir model. For the in-
teraction of ﬁbrinogen with NPs on the three surfaces, the Chi2
values as a percentage of Rmax were 9.9%, 10.5% and 10.7% on the
GLC, NLC and BGD surfaces, respectively. These results further
demonstrate that the three interactions ﬁtted, with some devia-
tions, to the model chosen.
For the interaction of ﬁbrinogen with CeO2 NPs on the GLC
surface the afﬁnity was 42 pM with ka of 5.13106 M1 s1, i.e.,
slightly faster than to TiO2, and kd of approximately 2104 s1,
i.e., slower (Fig. 3b and Table 1). On the NLC and BGD surfaces the
afﬁnity values were 37 and 41 pM, respectively, with a slightly
faster association constant, ka of 6106 M1 s1. However, on the
whole there is good agreement for the kinetic parameters for the
three surfaces with a ka value between 5 and 7106 M1 s1 and
kd around 2104 s1. As far as CeO2 is concerned, the afﬁnity
values are equivalent on the three surfaces studied and the results
reported here were not inﬂuenced by the nature of the surface
used to capture the NPs.
The Rmax values for the NLC and BGD surfaces were higher than
for the GLC surface (Table 1) and this reﬂects the greater numbers
of NPs captured on the NLC or BGD surface compared to the GLC
surface. The ﬁt lines (in black) show good agreement with the
experimental data and for all 3 surfaces the Chi2 value was less
than 10, with Chi2 values 6–11% of Rmax.
For the interaction of ﬁbrinogen with Al2O3 NPs on the GLC
surface, the afﬁnity was 17 nM with ka of 4.28104 M1 s1, i.e.,
two orders of magnitude slower than for TiO2 and CeO2 NPs, and
kd of 7.16104 s1, which is similar to that obtained for TiO2 and
slightly slower than for CeO2 NPs (2104 s1) (Fig. 3c and Ta-
ble 1). On the NLC and BGD surfaces the afﬁnity values were 11
and 14 nM, respectively, with a slightly faster association constant,
ka of 6104 M1 s1. The results show that the afﬁnities were
similar on the three surfaces. Therefore, it could be considered that
the constants reported are the result of the ﬁbrinogen–Al2O3 NP
interaction and they were not affected by the capture surface used.
The Rmax values for the GLC surface were higher than for the
other surfaces and this is due to the greater numbers of NPs
captured on the GLC surface compared to NLC or BGD surfaces, as
can be seen from Fig. 3c. For all three surfaces the Chi2 value was
less than 9 and this is indicative of a good ﬁt to the chosen model,
with the Chi2 being less than 14% of Rmax for all three surfaces.
For the interaction of ﬁbrinogen with ZnO NPs, despite thetemporarily high levels of NP immobilization achieved, the NPs
dissociate too rapidly from the chip surface. Thus, it was not
possible to obtain a stable surface with a sufﬁciently high level of
ZnO NPs to study the interaction with ﬁbrinogen.
3.2. Kinetic analysis of HSA with TiO2, CeO2, Al2O3 and ZnO NPs
For the interaction of HSAwith TiO2 NPs on the GLC surface, the
afﬁnity was 79 nM with ka1 of 1.88104 M1 s1, kd1 of
2.69102 s1, ka2 of 6.67103 s1 and kd2 of 3.66104 s1
(Fig. 4a and Table 2). On the NLC and BGD surfaces, the afﬁnity
values were 66 and 94 nM, respectively. ka1 and kd1 were between
1.64–1.88104 M1 s1 and 1.90–2.69 102 s1, and ka2 and kd2
were between 6.67–9.20103 s1 and 3.50–7.50 104 s1, re-
spectively. The results show good agreement between the three
surfaces.
The lower Rmax signal obtained on the BGD surface compared
with the GLC and NLC surfaces reﬂects the lower immobilization
level of the TiO2 NPs on this surface (Table 2 and Fig. 4a). The ﬁtted
kinetic parameters (Fig. 4a, black lines) show good agreement with
the experimental data. The Chi2 values were less than 10, the Chi2
values as a percentage of Rmax were 3.62%, 6.97% and 14.14% on the
GLC, NLC and BGD surfaces, respectively, and this provides statis-
tical evidence that the conformational model describes the HSA–
TiO2 NP interaction.
For the interaction of HSA with CeO2 NPs on the GLC surface, the
afﬁnity was 25 nM with ka1 of 3.49104 M1 s1, kd1 of
1.76102 s1, ka2 of 8.70103 s1 and kd2 of 4.30104 s1
(Fig. 4b and Table 2). ka1 is slightly faster than for TiO2 and more than
two orders of magnitude slower than ka for ﬁbrinogen
(6106 M1 s1). On the NLC and BGD surfaces, the afﬁnity values
were 45 and 40 nM, respectively. ka1 and kd1 were between 2.67–
3.49104 M1 s1 and 1.76–2.50 102 s1. ka2 and kd2 were be-
tween 8.15–9.70103 s–1 and 4.10–4.93 104 s1, respectively, thus
showing good agreement between the results on the three surfaces.
The Rmax values for the three surfaces were similar and this
shows that comparable numbers of NPs were captured on the
different surfaces. The Chi2 values were less than 10; the values of
Chi2 as a percentage of Rmax were 9.22%, 3.63% and 10.16% on the
GLC, NLC and BGD surfaces, respectively, which revealed that the
data ﬁt well to the conformational model.
For the interaction of HSA with Al2O3 NPs captured on the GLC
surface, the afﬁnity was 0.1 mM with ka1 of 2.34103 M1 s1, kd1
of 4.00102 s1, ka2 of 4.88103 s1 and kd2 of
4.00105 s1 (Fig. 4c and Table 2). ka1 is one order of magnitude
slower than for TiO2 and CeO2 NPs (104 M1 s1) and one order of
magnitude slower compared with ka for ﬁbrinogen binding. It was
proved that neither the NLC nor the BGD surfaces could be em-
ployed to capture sufﬁcient Al2O3 NPs and a GLH surface, which is
a higher capacity version of GLC, was therefore employed. Two
Fig. 4. Binding curves for HSA with TiO2, CeO2 and Al2O3 NPs. (a, b) Sensorgrams for the interaction of HSA with TiO2 and CeO2 NPs, respectively. The concentrations of HSA
injected in the GLC, NLC and BGD surfaces were 755, 377.5, 188.8, 94.4 and 47.2 nM. (c) Sensorgrams for the interaction of HSAwith Al2O3 NPs. On the GLC and GLH1 surfaces
the concentrations of HSA injected were 7.55, 3.77, 1.89, 0.94 and 0.47 μM. On the GLH2 surface the concentrations of HSA injected were 15.10, 7.55, 3.77, 1.89 and 0.94 μM.
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Fig. 4c and Table 2) obtaining different kinetic parameter values to
the GLC surface, with afﬁnity values of 3 mM and 2 mM, respec-
tively (Fig. 4c and Table 2). The ﬁtted data gave Chi2 values of less
than 10 and around 9–12% of the ﬁtted Rmax signal. The results
indicate that the data ﬁt, with some deviations, to the chosen
model (Fig. 4c).
In a similar way to the interaction with ﬁbrinogen, the inter-
action of HSA with ZnO NPs gave rise to a rapid dissociation
of the NPs from the chip surface and this prevented further studyTable 2
Binding constants for the interactions between HSA and TiO2, CeO2, and Al2O3 NPs.
NPs Chip ka1 (M1s1) kd1 (s1) KD (M)
TiO2 GLC 1.8870.02104 2.6970.06102 7.85108
TiO2 NLC 1.9770.04104 2.5770.08102 6.62108
TiO2 BGD 1.6470.04104 1.9070.10102 9.44108
CeO2 GLC 3.4970.05104 1.7670.06102 2.49108
CeO2 NLC 2.8070.70104 2.1070.01102 4.54108
CeO2 BGD 2.6770.06104 2.5070.10102 3.96108
Al2O3 GLC 2.3470.08103 4.0070.20102 1.40107
Al2O3 GLH 2.8070.30104 3.6070.40101 2.81106
Al2O3 GLH 3.7070.10103 5.2070.20102 2.23106
Three different chip surfaces were used: alginate (low and high capacity, GLC and GLH, re
for the rate constants are the standard error of the ﬁt from the global ﬁtting of 5 conceof this system.
The results of the kinetic analysis for all of the interactions of
ﬁbrinogen and HSA with the TiO2, CeO2 and Al2O3 NPs are pro-
vided in Tables 1 and 2. For the HSA–NP interaction, the ﬁtting to
other kinetic models, such as the Langmuir model or bivalent
analyte, was also performed for comparison. The values are shown
in Figs. S6 and S7 and Tables S4 and S5, respectively. The kinetic
constants, using the Langmuir model for ﬁbrinogen and HSA, are
represented as an isoafﬁnity graph (Fig. S8), which is a plot of
dissociation rate constants versus association rate constants.ka2 (s1) kd2 (s1) Rmax (RU) Chi2 (RU)
6.6770.07103 3.6670.08104 74.67 2.70
6.9070.10103 3.5070.10104 65.29 4.55
9.2070.30103 7.5070.10104 35.63 5.04
8.7070.10103 4.3070.10104 49.69 4.58
8.1570.05103 4.9370.07104 55.39 2.01
9.7070.20103 4.1070.10104 49.60 5.04
4.887 0.09103 4.0072.00105 39.62 3.40
3.6670.08103 8.0070.40104 25.46 3.06
4.9070.08103 7.8070.20104 31.25 3.81
spectively), NeutrAvidin (NLC) and bare gold (BGD). The standard deviations quoted
ntrations. The standard deviations for Rmax are in the range 0.65–0.14.
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Characterization of the interactions between proteins and
metal oxide NP surfaces is a challenging task. The use of SPR to
study the binding of ﬁbrinogen and HSA to TiO2, CeO2 and Al2O3
NPs provided real-time data for such interactions, which in con-
trast to end-point techniques such as ELISA or Western Blot de-
livers both the afﬁnity and kinetics of the interaction. The ro-
bustness of the technique affords the possibility of following the
binding of both proteins to metal oxide NPs using suitable ex-
perimental conditions such as different concentrations, im-
mobilization levels and chip surfaces depending on the NPs, pro-
teins and afﬁnities expected. Moreover, regeneration of the surface
by treatment with 0.5% SDS allowed experiments to be performed
in triplicate, except for the interaction of ﬁbrinogen–CeO2 on the
GLC, NLC and BGD surfaces which was performed in duplicate.
From the tables of rate constants (Tables 1 and 2), it can be
concluded that the afﬁnity between the NPs and the proteins is
higher with ﬁbrinogen than with HSA.
The interactions of CeO2 and TiO2 NPs with ﬁbrinogen were of
high afﬁnity with an average KD of 40 pM for CeO2 NPs and 134 pM
for TiO2 NPs, and a moderate afﬁnity interaction in the case of
Al2O3 NPs, with an average KD of 14 nM. In regard to HSA, all of the
interactions with the metal oxide NPs were of low afﬁnity and
they followed the same sequence of NP composition in terms of
afﬁnity as ﬁbrinogen, with an average KD of 37 nM for CeO2 NPs,
80 nM for TiO2 NPs and 2 mM for Al2O3 NPs.
TiO2, CeO2, Al2O3 and ZnO NPs were immobilized on diverse
chemical surfaces by physisorption, probably through electrostatic,
van der Waals forces, hydrophobic interactions and/or hydrogen
bonding (Hutmacher and Chrzanowski, 2015; Meyer et al., 2006).
The positive charge on the NPs and the negative carboxylate
groups on the alginate and NeutrAvidin chips promote the for-
mation and stabilization on the NP surface created. For instance, it
has been reported that TiO2 NPs can be immobilized on polymeric
substrates by electrostatic interactions (Matsuzawa et al., 2008).
In terms of the surface chemistries used to capture the NPs
through different interactions, it was observed that for the inter-
action of both ﬁbrinogen and HSA the reported afﬁnities were not
signiﬁcantly inﬂuenced by the capture chemistry surface used for
the NP immobilization. However, in the case of the interaction of
HSA with Al2O3 NPs, only the GLC and GLH surfaces provided
quantitative values. In spite of the low afﬁnity of the HSA to Al2O3
NPs, the sensitivity of SPR allows this interaction to be measured
whereas ﬂuorescence or Fourier-transform infrared (FTIR) spec-
troscopy was unable to measure this. Previous spectroscopy and
DLS results showed that the interaction of the NPs with HSA does
not induce any changes in the ﬂuorescence and FTIR spectra and
nor does it reduce the aggregation of the Al2O3 NPs, as measured
by DLS and in contrast to the observations for the rest of the metal
oxide NPs studied (Simon-Vazquez et al. 2014).
On the BGD chip, which has a very low level of charge, in order
to eliminate the drift of the TiO2 and CeO2 NP surfaces, probably
due to a certain degree of dissociation of the NPs from the chip,
Al2O3 NPs were immobilized as a negative control surface at the
protein concentrations used to study the interactions. For example,
the protein concentration injected to study the ﬁbrinogen–Al2O3
NP interaction was 62.5 times higher than the concentration used
to study the interaction with the TiO2 and CeO2 NPs. The un-
referenced sensorgrams of the interactions are shown in the
Supplementary information (Figs. S4 and S5) and it can be ob-
served how the Al2O3 surface bound little or no protein compared
to TiO2 and CeO2 NPs captured onto the Al2O3 NPs with Au as the
underlying capture surface. Subsequently, the CeO2 and TiO2 NPs
were immobilized on the Al2O3 NPs surface to give a more stable
surface.Whilst the ﬁbrinogen–NP interactions ﬁtted very well to the
1:1 Langmuir model (Fig. 3), the kinetics of the HSA–NP interac-
tions did not ﬁt well to this model (Fig. S6). The conformational
change model was applied to these interactions instead, due to the
fact that in a previous work, and using spectroscopy techniques,
we showed that TiO2 and CeO2 NPs seem to induce conformational
changes on HSA (Simon-Vazquez et al., 2014). Nevertheless, the
Langmuir model was also applied and apparent rate constants
were quoted (Fig. S6 and Table S4). Besides, the Langmuir model
allows the comparison between the kinetics and afﬁnities of both
protein interactions (Fig. S8). Moreover, although the bivalent
analyte model was also tested (Fig. S7 and Table S5), the high Rmax
generated indicates that the data did not ﬁt well to the model.
Evaluation of the interaction of ZnO NPs with ﬁbrinogen and
HSA failed to provide any results. Although these materials were
initially captured well on the chip surface with high levels of im-
mobilization, they quickly started to dissociate and this prevented
to study their interaction with the proteins. As a consequence, the
opposite strategy was performed. The proteins were immobilized
on the sensor chip and the ZnO NPs were injected as analytes.
However, once again conclusive results were not obtained with
these NPs. It is possible that the electrostatic interaction of the ZnO
NPs with the gold surface and a high degree of aggregation of the
NPs interfered with the measurements. For this reason, the in-
teraction of ZnO NPs with plasma proteins does not seem to be
suitable for study by SPR. However, other studies of these inter-
actions by ﬂuorescence, FTIR and circular dichroism (CD) spec-
troscopy have shown that the ZnO NPs induce the most marked
protein conformational changes of the four metal oxide NPs stu-
died (Simon-Vazquez et al. 2014).
The results are in consistent with those obtained in previous
studies on blood plasma adsorption at surfaces, which showed
that initial protein binding was predominant to albumin, the most
abundant protein, and this was replaced over time by the ﬁ-
brinogen, which had a lower concentration but a higher afﬁnity
(Aggarwal et al., 2009; Ehrenberg et al., 2009).5. Conclusion
SPR was used to analyze the interaction of four metal oxide
nanoparticles (TiO2, CeO2, Al2O3 and ZnO) with two human plasma
proteins, albumin and ﬁbrinogen, by direct immobilization of the
NPs on different functionalized surfaces (GLC, GLH and NLC chip)
or a bare surface (BGD chip). The proteins were injected over the
NP surface and both the kinetics and the afﬁnity of the interaction
were measured. The SPR measurements showed that the binding
of proteins to these NPs is reversible and the results in the dif-
ferent sensor chips were similar. However, the interaction of
proteins with ZnO NPs was not suitable for study by the SPR. The
results show that ﬁbrinogen is a high afﬁnity protein and the data
ﬁtted well to the 1:1 Langmuir model. In contrast, HSA is a low
afﬁnity protein and the data ﬁt better to the two states con-
formational change model. Among the metal oxide NPs used in
this work, the CeO2 NPs showed a higher afﬁnity than the TiO2 NPs
and the Al2O3 NPs had the lowest afﬁnity for the plasma proteins
studied.
We believe that this study highlights the potential of direct
metal oxide NP immobilization on chip surfaces for the quantita-
tive assessment of binding with proteins injected as analytes. The
characterization of these interactions is important due to the po-
tential of these NPs in biomedical applications. The protein bind-
ing on the NP surface inﬂuences their biodistribution and cellular
uptake; hence their characterization is very relevant to study the
efﬁcacy and toxicology of NPs in the human body.
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